Heart repair factor

A signaling factor called Wnt10b is a novel target for optimizing cardiac repair after a heart attack.

VU first to offer new implantable defibrillator

Vanderbilt is the first hospital in Tennessee to use a new subcutaneous implantable defibrillator (S-ICD) to treat patients at risk for sudden cardiac arrest.

Preventing hardened heart valves

Blocking a serotonin receptor may provide a novel therapy for heart valve disease.

VUMC to launch live video chat series Nov. 9

Vanderbilt rolls out Level 1 Cardiac Emergency System

Vanderbilt Heart to participate in CoreValve clinical trial

Vanderbilt Heart will soon begin testing the safety of a novel, non-surgical approach to treating aortic stenosis, a common heart problem caused by an abnormal narrowing of the heart’s aortic valve.